and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he's on a reverie associate professor and clinical biologist at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered ok so we do have some dates on 1st if it is c. or both the vaccines. and the others and seeing all the little trials were not designed to test 1st it's the only protection we're from since our experience with those vaccines is that the 1st those actually does most of the work the 2nd those just. so most people respond to those 1st as well as to use sufficient sufficient immunity that commuter the beast is exposed to the virus in the population. but but this is not how they were designed certainly by ontic pfizer already mentioned that they they are a bit dubious about extending the period between those one and today's 2 so how big is the risk that extending the period between the 1st of the 2nd j

and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he is honorary associate professor and clinical biologist at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered. ok so we do have some dates on 1st if it is c. for both the vaccines. and the other some of the vaccine although the clinical trials were not designed to test 1st as if it is the only we could see some protection were there from other vaccines our experience with those vaccines is that the 1st those actually does most of the work with the 2nd that's just being abused so most people respond the 1st is the 1st as well as to use a sufficient sufficient immunity that commute for the beast of by exposure the virus in the population right the 2nd dose is ready but but this is not how they were designed certainly by and take pfizer already mentioned that they they have been dubious about extending the per

and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he is honorary associate professor and clinical biologist at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered. ok so we do have some data on 1st if it is c. for both the vaccines. and the others and the vaccine although little trials were not designed to test 1st as if that is the only d.c. some protection we there from other vaccines our experience with those vaccines is that the 1st those actually just most of the work with the 2nd this is being abused so most people respond the 1st is the 1st as well as use a sufficient sufficient immunity that commute for the bees to exposure the virus in the population rise of a 2nd those ready but but this is not how they were designed certainly by and take pfizer already mentioned that they they have been dubious about extending the period between those wanted to doz

and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he is honorary associate professor and clinical biologist at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered. ok so you do have some dates on 1st if it is c. for both the vaccines. and the president about seeing all the little trials were not designed to test 1st as if it is the only some protection we there from other vaccines are exposed to those vaccines is that the 1st those she does most of the work with the 2nd this is being abused so most people respond the 1st is the 1st as will it use sufficient sufficient immunity that commuter the beast the exposure the virus in the population rise of a 2nd those are just ready but but this is not how they were designed certainly by and take pfizer already mentioned that they they have been dubious about extending the period between those wanted to doze to so ho

and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he is honorary associate professor and clinical by religious at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered. ok so you do have some data on 1st if it is c. for both the vaccines. and the president about seeing all the little trials were not designed to test 1st if it is the only we do see some protection where they're from other vaccines are exposed to those that since it's not the 1st those actually does most of the work with the 2nd this is being abused so most people respond the 1st is the food as well as use sufficient sufficient immunity that commuter the beast the exposure the virus in the population of the 2nd dose is ready but but this is not how they were designed certainly by and take out pfizer already mentioned that they they have been dubious about extending the period between those wanted

and for many getting a brand new vaccine is already a leap of faith so let's talk more now with julian tung he's on a reverie associate professor and clinical biologist at the university of leicester good to have you with us tell me isn't it a bit risky to change the way we use those vaccines on patients without proper clinical trials to back up those changes as to how the vaccines are administered. ok so we do have some dates on if it is c. or both vaccines are on the scene although to go trials are not designed to test 1st as if it is the only some protection we're from other vaccines our experience with those vaccines is that the 1st those actually just most of the work the 2nd there's just. so most people respond to the 1st as well as use a sufficient sufficient immunity that commuter the beast is exposed to the virus in the population. but but this is not how they were designed certainly by on tech already mentioned that they they are a bit dubious about extending the period between those wanted to doze too so how big is the risk that extending the period between the 1st of the 2nd job